Status:

RECRUITING

Newly-diagnosed Low Risk Pediatric B-cell ALL Protocol

Lead Sponsor:

Institute of Hematology & Blood Diseases Hospital, China

Conditions:

Acute Lymphoblastic Leukemia ALL

Childhood Leukemia, Acute Lymphoblastic

Eligibility:

All Genders

1-18 years

Phase:

PHASE2

PHASE3

Brief Summary

CCCG-ALL2025 LR-B-ALL plan is designed based on the CCCG-ALL2020 plan. This is a clinical trial using 14 days of blinatumomab (Blina-14) as early intensification after induction therapy and 2nd Blina-...

Detailed Description

1. All LR-B-ALL patients will be treated with 14 days of blinatumomab (Blina-14) as early intensification to replace CAT+ (historically given in LR-B-AL with MRD19\>0.1% in the 2020 protocol). 2. Two ...

Eligibility Criteria

Inclusion

  • Must meet all items below:
  • Age older than 1 year and younger than 18 years.
  • Diagnosis of acute lymphoblastic leukemia by bone marrow morphology.
  • Diagnosis of B-ALL by immunophenotyping.
  • Low risk group

Exclusion

  • Should be excluded in the presence of any item below:
  • T-ALL
  • I/HR B-ALL group
  • sIgM+
  • Acute leukemias of ambiguous lineage diagnosed according to WHO or EGIL criteria.
  • Philadelphia chromosome positive ALL (Ph-ALL)
  • ALL evolved from chronic myeloid leukemia (CML).
  • Down's syndrome, or major congenital or hereditary disease with organ dysfunction
  • Secondary leukemia
  • Known underlying congenital immunodeficiency or metabolic disease
  • Congenital heart disease with cardiac insufficiency.
  • Glucocorticoid treatment for ≥14 days, or ABL kinase inhibitors for \> 7 days within one month before enrollment, or any chemotherapy or radiotherapy within 3 months before enrollment (except for emergency radiotherapy to relieve airway compression)

Key Trial Info

Start Date :

March 3 2025

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

June 1 2033

Estimated Enrollment :

3000 Patients enrolled

Trial Details

Trial ID

NCT06882057

Start Date

March 3 2025

End Date

June 1 2033

Last Update

August 26 2025

Active Locations (27)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 7 (27 locations)

1

Anhui Medical University Second Affiliated Hospital

Hefei, Anhui, China

2

Anhui Provincial Children's Hospital

Hefei, Anhui, China

3

Chongqing Medical University Affiliated Children's Hospital

Chongqing, Chongqing Municipality, China

4

Fujian Medical University Union Hospital

Fuzhou, Fujian, China